Novo Nordisk CFO on Earnings, Insulin Prices

Novo Nordisk CFO on Earnings, Insulin Prices Play

Aug. 4 (Bloomberg) -- Jesper Brandgaard, chief financial officer of Novo Nodrisk A/S, talks about the company's second-quarter profit reported today and the effects of European governments' spending cuts. Novo Nordisk is the world's biggest maker of insulin. Brandgaard speaks with Francine Lacqua on Bloomberg Television's "On the Move." (Source: Bloomberg)

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus